PanTHERA CryoSolutions is pleased to announce that it has been awarded $180,616 in grant funding with the Accelerating Innovations into CarE (AICE) – Validate Program from Alberta Innovates. PanTHERA CryoSolutions would like to acknowledge Alberta Innovates for the support in pioneering efforts to advance cryopreservation technology and revolutionizing the industry.
Cryopreservation plays a vital role in various fields, including cell therapy applications. PanTHERA CryoSolutions is at the forefront of developing cutting-edge cryopreservation solutions that address the challenges faced by industries relying on long-term storage of biological samples used in cell therapy applications.
The grant provided by Alberta Innovates will enable PanTHERA CryoSolutions to accelerate the commercial readiness of the novel Ice Recrystallization Inhibitors by increasing manufacturing scale and optimizing the quality of the manufacturing process. The grant will go a long way in making a difference ensuring that the product is validated through third party collaborations.
Dr. Jason Acker, CEO and Co-Founder of PanTHERA CryoSolutions, expressed his gratitude for the grant stating, ‘We are honored to receive this grant from Alberta Innovates. This funding will be instrumental in furthering our mission of revolutionizing cryopreservation technology.’
This grant recognizes the potential impact of PanTHERA CryoSolutions’ innovative approach to cryopreservation and the value it brings to the biotechnology industry. The organization is committed to supporting companies that drive advancements in various scientific domains to create a more prosperous and sustainable future for Alberta and beyond.
PanTHERA CryoSolutions remains committed to advancing cryopreservation technology, and with the support of Alberta Innovates, the company is poised to advance the commercialization of the product and the revenues from commercialization will allow PanTHERA CryoSolutions to expand our evaluation and validation of the technology to the many other areas that this technology is also applicable.
About PanTHERA CryoSolutions
PanTHERA CryoSolutions is a Canadian corporation that designs and manufactures cryopreservation solutions for cells, tissues and organs. Our patented ice recrystallization inhibitor (IRI) technology enhances currently available alternatives and increasing post-thaw cell recovery and function and providing superior cryopreservation for our customers.
